Skip to main content
. Author manuscript; available in PMC: 2016 Oct 3.
Published in final edited form as: Gynecol Oncol. 2011 Oct 19;124(1):148–152. doi: 10.1016/j.ygyno.2011.09.037

Fig. 1.

Fig. 1

A: Normal endometrium showed negative expression for synuclein (magnification ×40). B: Uterine serous carcinoma with strong positivity for SNCG (magnification ×40). C: Clear cell carcinoma with negative immunoexpression for SNCG (magnification ×40). D: Endometrioid adenocarcinoma FIGOIII (left upper corner marked by asterisk) strongly expressing SNCG immunostain, while the normal glands (marked in an arrow) are negative for SNCG expression (×40).